Staphylococcus aureus binding to Seraph® 100 Microbind® Affinity Filter: Effects of surface protein expression and treatment duration.

<h4>Introduction</h4>Extracorporeal blood purification systems represent a promising alternative for treatment of blood stream infections with multiresistant bacteria.<h4>Objectives</h4>The aim of this study was to analyse the binding activity of S. aureus to Seraph affinity...

Full description

Bibliographic Details
Main Authors: Malin-Theres Seffer, Martin Weinert, Gabriella Molinari, Manfred Rohde, Lothar Gröbe, Jan T Kielstein, Susanne Engelmann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0283304
_version_ 1827963396292608000
author Malin-Theres Seffer
Martin Weinert
Gabriella Molinari
Manfred Rohde
Lothar Gröbe
Jan T Kielstein
Susanne Engelmann
author_facet Malin-Theres Seffer
Martin Weinert
Gabriella Molinari
Manfred Rohde
Lothar Gröbe
Jan T Kielstein
Susanne Engelmann
author_sort Malin-Theres Seffer
collection DOAJ
description <h4>Introduction</h4>Extracorporeal blood purification systems represent a promising alternative for treatment of blood stream infections with multiresistant bacteria.<h4>Objectives</h4>The aim of this study was to analyse the binding activity of S. aureus to Seraph affinity filters based on heparin coated beads and to identify effectors influencing this binding activity.<h4>Results</h4>To test the binding activity, we used gfp-expressing S. aureus Newman strains inoculated either in 0.9% NaCl or in blood plasma and determined the number of unbound bacteria by FACS analyses after passing through Seraph affinity filters. The binding activity of S. aureus was clearly impaired in human plasma: while a percent removal of 42% was observed in 0.9% NaCl (p-value 0.0472) using Seraph mini columns, a percent removal of only 10% was achieved in human plasma (p-value 0.0934). The different composition of surface proteins in S. aureus caused by the loss of SarA, SigB, Lgt, and SaeS had no significant influence on its binding activity. In a clinically relevant approach using the Seraph® 100 Microbind® Affinity Filter and 1000 ml of human blood plasma from four different donors, the duration of treatment was shown to have a critical effect on the rate of bacterial reduction. Within the first four hours, the number of bacteria decreased continuously and the reduction in bacteria reached statistical significance after two hours of treatment (percentage reduction 64%, p-value 0.01165). The final reduction after four hours of treatment was close to 90% and is dependent on donor. The capacity of Seraph® 100 for S. aureus in human plasma was approximately 5 x 108 cells.<h4>Conclusions</h4>The Seraph affinity filter, based on heparin-coated beads, is a highly efficient method for reducing S. aureus in human blood plasma, with efficiency dependent on blood plasma composition and treatment duration.
first_indexed 2024-04-09T16:58:23Z
format Article
id doaj.art-ab298a2e3f4345eb87ba6fd29b5640e2
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-09T16:58:23Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ab298a2e3f4345eb87ba6fd29b5640e22023-04-21T05:34:45ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01183e028330410.1371/journal.pone.0283304Staphylococcus aureus binding to Seraph® 100 Microbind® Affinity Filter: Effects of surface protein expression and treatment duration.Malin-Theres SefferMartin WeinertGabriella MolinariManfred RohdeLothar GröbeJan T KielsteinSusanne Engelmann<h4>Introduction</h4>Extracorporeal blood purification systems represent a promising alternative for treatment of blood stream infections with multiresistant bacteria.<h4>Objectives</h4>The aim of this study was to analyse the binding activity of S. aureus to Seraph affinity filters based on heparin coated beads and to identify effectors influencing this binding activity.<h4>Results</h4>To test the binding activity, we used gfp-expressing S. aureus Newman strains inoculated either in 0.9% NaCl or in blood plasma and determined the number of unbound bacteria by FACS analyses after passing through Seraph affinity filters. The binding activity of S. aureus was clearly impaired in human plasma: while a percent removal of 42% was observed in 0.9% NaCl (p-value 0.0472) using Seraph mini columns, a percent removal of only 10% was achieved in human plasma (p-value 0.0934). The different composition of surface proteins in S. aureus caused by the loss of SarA, SigB, Lgt, and SaeS had no significant influence on its binding activity. In a clinically relevant approach using the Seraph® 100 Microbind® Affinity Filter and 1000 ml of human blood plasma from four different donors, the duration of treatment was shown to have a critical effect on the rate of bacterial reduction. Within the first four hours, the number of bacteria decreased continuously and the reduction in bacteria reached statistical significance after two hours of treatment (percentage reduction 64%, p-value 0.01165). The final reduction after four hours of treatment was close to 90% and is dependent on donor. The capacity of Seraph® 100 for S. aureus in human plasma was approximately 5 x 108 cells.<h4>Conclusions</h4>The Seraph affinity filter, based on heparin-coated beads, is a highly efficient method for reducing S. aureus in human blood plasma, with efficiency dependent on blood plasma composition and treatment duration.https://doi.org/10.1371/journal.pone.0283304
spellingShingle Malin-Theres Seffer
Martin Weinert
Gabriella Molinari
Manfred Rohde
Lothar Gröbe
Jan T Kielstein
Susanne Engelmann
Staphylococcus aureus binding to Seraph® 100 Microbind® Affinity Filter: Effects of surface protein expression and treatment duration.
PLoS ONE
title Staphylococcus aureus binding to Seraph® 100 Microbind® Affinity Filter: Effects of surface protein expression and treatment duration.
title_full Staphylococcus aureus binding to Seraph® 100 Microbind® Affinity Filter: Effects of surface protein expression and treatment duration.
title_fullStr Staphylococcus aureus binding to Seraph® 100 Microbind® Affinity Filter: Effects of surface protein expression and treatment duration.
title_full_unstemmed Staphylococcus aureus binding to Seraph® 100 Microbind® Affinity Filter: Effects of surface protein expression and treatment duration.
title_short Staphylococcus aureus binding to Seraph® 100 Microbind® Affinity Filter: Effects of surface protein expression and treatment duration.
title_sort staphylococcus aureus binding to seraph r 100 microbind r affinity filter effects of surface protein expression and treatment duration
url https://doi.org/10.1371/journal.pone.0283304
work_keys_str_mv AT malintheresseffer staphylococcusaureusbindingtoseraph100microbindaffinityfiltereffectsofsurfaceproteinexpressionandtreatmentduration
AT martinweinert staphylococcusaureusbindingtoseraph100microbindaffinityfiltereffectsofsurfaceproteinexpressionandtreatmentduration
AT gabriellamolinari staphylococcusaureusbindingtoseraph100microbindaffinityfiltereffectsofsurfaceproteinexpressionandtreatmentduration
AT manfredrohde staphylococcusaureusbindingtoseraph100microbindaffinityfiltereffectsofsurfaceproteinexpressionandtreatmentduration
AT lothargrobe staphylococcusaureusbindingtoseraph100microbindaffinityfiltereffectsofsurfaceproteinexpressionandtreatmentduration
AT jantkielstein staphylococcusaureusbindingtoseraph100microbindaffinityfiltereffectsofsurfaceproteinexpressionandtreatmentduration
AT susanneengelmann staphylococcusaureusbindingtoseraph100microbindaffinityfiltereffectsofsurfaceproteinexpressionandtreatmentduration